Survivin as a universal tumor antigen for novel cancer immunotherapy: functions of a killer clone.

Abstract
Commentary to: A survivin specific T-cell clone from a breast cancer patient displays universal tumor cell lysis Rikke Bæk Sørensen, Inge Marie Svane, Per thor Straten, Mads Hald Andersen